Hepatitis B modelling

We use mathematical and economic models to inform global efforts to achieving the elimination of hepatitis B as a public health threat.

We're aiming to answer the following questions in a range of settings:

• How can different vaccine technologies or delivery strategies be used to increase the coverage of timely birth dose vaccination?
• What is the expected return-on-investment from achieving hepatitis B elimination targets, including productivity benefits?
• How can budgets be optimised to achieve the greatest impact?